Resultados de la búsqueda 91-100 of 15864 for Réactions secondaires à la vaccination contre le zona

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to monitor T cell responses from patients with advanced cancer who are being treated with an anti-PD (programmed ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to assess the presence of various molecular markers in histiocytic disorders. In addition to this, to review ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 ...

  5. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Many of the current imaging tests we have for prostate cancer are problematic in their ability to distinguish cancerous from non-cancerous prostate tissue. This ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...